Eric Schoenmakers
Analyst-Equity bei Point Sur Investors LLC
Profil
Dr. Eric Schoenmakers is an Equity Research Senior Analyst at Point Sur Investors LLC.
Dr. Schoenmakers worked as an independent consultant providing services across his wide spectrum of expertise, including Preclinical R&D, Translational Medicine, Biomarker and CDx Development, and GxP/Quality Management.
Before that he served as a Director Clinical Genetics within the Translational Medicine team at Pharmacyclics, Inc. Prior to joining Pharmacyclics, he headed the Pfizer Oncology Clinical Research Laboratory at Pfizer’s Global R&D site in La Jolla, CA.
He started his career in academia, and was a tenured faculty member at the Department of Human Genetics in Nijmegen, The Netherlands for over a decade.
He earned a MSc.
in Biology (with majors in Molecular Biology, Genetics, and Immunology) at the University of Nijmegen, The Netherlands, and a summa cum laude doctorate in Human (Cancer) Genetics from the University of Leuven, Belgium.
Aktive Positionen von Eric Schoenmakers
Unternehmen | Position | Beginn |
---|---|---|
Point Sur Investors LLC
Point Sur Investors LLC Investment ManagersFinance Point Sur Investors LLC provides investment advice. The private company is based in El Cerrito, CA and has subsidiaries in the United States. The company was founded in 2015 by Thomas Butler, Rainer M. Erdtmann. | Analyst-Equity | - |
Ehemalige bekannte Positionen von Eric Schoenmakers
Unternehmen | Position | Ende |
---|---|---|
Pharmacyclics, Inc.
Pharmacyclics, Inc. Pharmaceuticals: MajorHealth Technology Pharmacyclics, Inc. develops drugs to treat cancer. The private company is based in Sunnyvale, CA. Robert William Duggan has been the CEO of the company since 2015. | Corporate Officer/Principal | 01.05.2016 |
Pfizer (La Jolla)
Pfizer (La Jolla) Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Pfizer (La Jolla) is a company that provides research services. The company is based in San Diego, CA. The company was founded by Michael R. Jirousek. | Corporate Officer/Principal | 01.11.2012 |
Ausbildung von Eric Schoenmakers
Leuven University College | Doctorate Degree |
Radboud University Nijmegen | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Point Sur Investors LLC
Point Sur Investors LLC Investment ManagersFinance Point Sur Investors LLC provides investment advice. The private company is based in El Cerrito, CA and has subsidiaries in the United States. The company was founded in 2015 by Thomas Butler, Rainer M. Erdtmann. | Finance |
Pharmacyclics, Inc.
Pharmacyclics, Inc. Pharmaceuticals: MajorHealth Technology Pharmacyclics, Inc. develops drugs to treat cancer. The private company is based in Sunnyvale, CA. Robert William Duggan has been the CEO of the company since 2015. | Health Technology |
Pfizer (La Jolla)
Pfizer (La Jolla) Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Pfizer (La Jolla) is a company that provides research services. The company is based in San Diego, CA. The company was founded by Michael R. Jirousek. | Commercial Services |